|
1
|
Guerriero E, Sorice A, Capone F,
Napolitano V, Colonna G, Storti G, Castello G and Costantini S:
Vitamin C effect on mitoxantrone-induced cytotoxicity in human
breast cancer cell lines. PLos One. 9:e1152872014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iwamoto T: Clinical application of drug
delivery systems in cancer chemotherapy: Review of the efficacy and
side effects of approved drugs. Biol Pharm Bull. 36:715–718. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Smith L, Watson MB, O'Kane SL, Drew PJ,
Lind MJ and Cawkwell L: The analysis of doxorubicin resistance in
human breast cancer cells using antibody microarrays. Mol Cancer
Ther. 5:2115–2120. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rashid S, Ali N, Nafees S, Ahmad ST,
Arjumand W, Hasan SK and Sultana S: Alleviation of
doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in
Wistar rats. Toxicol Mech Methods. 23:337–345. 2013. View Article : Google Scholar
|
|
5
|
Rai G, Mishra S, Suman S and Shukla Y:
Resveratrol improves the anticancer effects of doxorubicin in vitro
and in vivo models: A mechanistic insight. Phytomedicine.
23:233–242. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thakur JS, Chauhan CG, Diwana VK, Chauhan
DC and Thakur A: Extravasational side effects of cytotoxic drugs: A
preventable catastrophe. Indian J Plast Surg. 41:145–150. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Desai AG, Qazi GN, Ganju RK, El-Tamer M,
Singh J, Saxena AK, Bedi YS, Taneja SC and Bhat HK: Medicinal
plants and cancer chemoprevention. Curr Drug Metab. 9:581–591.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vinod BS, Maliekal TT and Anto RJ:
Phytochemicals as chemosensitizers: From molecular mechanism to
clinical significance. Antioxid Redox Signal. 18:1307–1348. 2013.
View Article : Google Scholar
|
|
9
|
Divakaran SA and Nai CKK: Amelioration of
doxorubicin induced cardiotoxicity in tumor bearing mice by ferulic
acid: A mechanistic study at cellular and biochemical level. Int J
Tumor Ther. 1:6–13. 2012. View Article : Google Scholar
|
|
10
|
Chegaev K, Riganti C, Rolando B, Lazzarato
L, Gazzano E, Guglielmo S, Ghigo D, Fruttero R and Gasco A:
Doxorubicin-antioxidant co-drugs. Bioorg Med Chem Lett.
23:5307–5310. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goyal A, Sharma V, Upadhyay N, Gill S and
Sihag M: Flax and flaxseed oil: An ancient medicine & modern
functional food. J Food Sci Technol. 51:1633–1653. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Truan JS, Chen JM and Thompson LU:
Comparative effects of sesame seed lignan and flaxseed lignan in
reducing the growth of human breast tumors (MCF-7) at high levels
of circulating estrogen in athymic mice. Nutr Cancer. 64:65–71.
2012. View Article : Google Scholar
|
|
13
|
Sorice A, Guerriero E, Volpe MG, Capone F,
La Cara F, Ciliberto G, Colonna G and Costantini S: Differential
response of two human breast cancer cell lines to the phenolic
extract from flaxseed oil. Molecules. 21:3192016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Capone F, Guerriero E, Sorice A, Colonna
G, Storti G, Pagliuca J, Castello G and Costantini S: Synergistic
antitumor effect of doxorubicin and tacrolimus (FK506) on
hepatocellular carcinoma cell lines. Sci World J. 2014:4503902014.
View Article : Google Scholar
|
|
15
|
Tirosh O, Sen CK, Roy S, Kobayashi MS and
Packer L: Neuroprotective effects of alpha-lipoic acid and its
positively charged amide analogue. Free Radic Biol Med.
26:1418–1426. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chou TC: Theoretical basis, experimental
design, and computerized simulation of synergism and antagonism in
drug combination studies. Pharmacol Rev. 58:621–681. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Porichi O, Nikolaidou ME, Apostolaki A,
Tserkezoglou A, Arnogiannaki N, Kassanos D, Margaritis L and
Panotopoulou E: BCL-2, BAX and P53 expression profiles in
endometrial carcinoma as studied by real-time PCR and
immunohistochemistry. Anticancer Res. 29:3977–3982. 2009.PubMed/NCBI
|
|
18
|
Stefanowicz-Hajduk J, Bartoszewski R,
Bartoszewska S, Kochan K, Adamska A, Kosiński I and Ochocka JR:
Pennogenyl saponins from Paris quadrifolia L. induce extrinsic and
intrinsic pathway of apoptosis in human cervical cancer HeLa cells.
PLoS One. 10:e01359932015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang G, Zhang J, Liu L, Sharma S and Dong
Q: Quercetin potentiates doxorubicin mediated antitumor effects
against liver cancer through p53/Bcl-xl. PloS One. 7:e517642012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maggio M, Artoni A, Lauretani F, Borghi L,
Nouvenne A, Valenti G and Ceda GP: The impact of omega-3 fatty
acids on osteoporosis. Curr Pharm Des. 15:4157–4164. 2009.
View Article : Google Scholar
|
|
21
|
Rodriguez-Leyva D, Dupasquier CM,
McCullough R and Pierce GN: The cardiovascular effects of flaxseed
and its omega-3 fatty acid, α-linolenic acid. Can J Cardiol.
26:489–496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mason JK, Fu M, Chen J and Thompson LU:
Flaxseed oil enhances the effectiveness of trastuzumab in reducing
the growth of HER2-overexpressing human breast tumors (BT-474). J
Nutr Biochem. 26:16–23. 2015. View Article : Google Scholar
|
|
23
|
Sharifi S, Barar J, Hejazi MS and Samadi
N: Doxorubicin changes Bax/Bcl-xL ratio, caspase-8 and 9 in breast
cancer cells. Adv Pharm Bull. 5:351–359. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meiyanto E, Fitriasari A, Hermawan A,
Junedi S and Susidarti RA: The improvement of doxorubicin activity
on breast cancer cell lines by tangeretin through cell cycle
modulation. Orient Pharm Exp Med. 11:183–190. 2011. View Article : Google Scholar
|
|
25
|
Cheng YY, Yang JS, Tsai SC, Liaw CC, Chung
JG, Huang LJ, Lee KH, Lu CC, Chien HC, Tsuzuki M, et al: The newly
synthesized
2-(3-hydroxy-5-methoxyphenyl)-6,7-methylene-dioxyquinolin-4-one
triggers cell apoptosis through induction of oxidative stress and
upregulation of the p38 MAPK signaling pathway in HL-60 human
leukemia cells. Oncol Rep. 28:1482–1490. 2012.PubMed/NCBI
|
|
26
|
Fulda S and Debatin KM: Extrinsic versus
intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene.
25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang F, Chen H, Liu Y, Yin K, Wang Y, Li
X, Wang G, Wang S, Tan X, Xu C, et al: Doxorubicin caused apoptosis
of mesenchymal stem cells via p38, JNK and p53 pathway. Cell
Physiol Biochem. 32:1072–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal
A, Vandergriff J, Rabkin S, Guo N, Muruganujan A, Doremieux O,
Campbell MJ, et al: The PANTHER database of protein families,
subfamilies, functions and pathways. Nucleic Acids Res.
33:D284–D288. 2005. View Article : Google Scholar :
|
|
29
|
Ortiz MA, Lopez-Hernandez FJ, Bayon Y,
Pfahl M and Piedrafita FJ: Retinoid-related molecules induce
cytochrome c release and apoptosis through activation of c-Jun
NH(2)-terminal kinase/p38 mitogen-activated protein kinases. Cancer
Res. 61:8504–8512. 2001.PubMed/NCBI
|
|
30
|
Chuang SM, Wang IC and Yang JL: Roles of
JNK, p38 and ERK mitogen-activated protein kinases in the growth
inhibition and apoptosis induced by cadmium. Carcinogenesis.
21:1423–1432. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ding H, Gabali AM, Jenson SD, Lim MS and
Elenitoba-Johnson KS: P38 mitogen activated protein kinase
expression and regulation by interleukin-4 in human B cell
non-Hodgkin lymphomas. J Hematop. 2:195–204. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Parrish AB, Freel CD and Kornbluth S:
Cellular mechanisms controlling caspase activation and function.
Cold Spring Harb Perspect Biol. 5:a0086722013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jin Z and El-Deiry WS: Overview of cell
death signaling pathways. Cancer Biol Ther. 4:139–163. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Merhi F, Tang R, Piedfer M, Mathieu J,
Bombarda I, Zaher M, Kolb JP, Billard C and Bauvois B: Hyperforin
inhibits Akt1 kinase activity and promotes caspase-mediated
apoptosis involving Bad and Noxa activation in human myeloid tumor
cells. PloS One. 6:e259632011. View Article : Google Scholar : PubMed/NCBI
|
